Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1963 Jun;38(199):208–214. doi: 10.1136/adc.38.199.208

Aldolase Activity in the Plasma or Serum of Normal Children and Families with Muscular Dystrophy

Barbara E Clayton, K Margaret Wilson, Cedric O Carter
PMCID: PMC2019036  PMID: 14021638

Full text

PDF
208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER R. W., EVANS J. H. Serum aldolase and the diagnosis of myopathy. Brain. 1957 Dec;80(4):557–570. doi: 10.1093/brain/80.4.557. [DOI] [PubMed] [Google Scholar]
  2. BECKER P. E. Zur Genetik der Myopathien. Dtsch Z Nervenheilkd. 1955;173(5-6):482–498. [PubMed] [Google Scholar]
  3. BLYTH H., PUGH R. J. Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance. Ann Hum Genet. 1959 Apr;23(2):127–163. doi: 10.1111/j.1469-1809.1958.tb01457.x. [DOI] [PubMed] [Google Scholar]
  4. CHUNG C. S., MORTON N. E., PETERS H. A. Serum enzymes and genetic carriers in muscular dystrophy. Am J Hum Genet. 1960 Mar;12:52–66. [PMC free article] [PubMed] [Google Scholar]
  5. FRIEDMAN M. M., LAPAN B. Serum aldolase in the neonatal period: including a colorimetric determination of aldolase by standardization with dihydroxyacetone. J Lab Clin Med. 1958 May;51(5):745–752. [PubMed] [Google Scholar]
  6. HUGHES B. P. Serum enzymes in carriers of muscular dystrophy. Br Med J. 1962 Oct 13;2(5310):963–964. doi: 10.1136/bmj.2.5310.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LEYBURN P., THOMSON W. H., WALTON J. N. An investigation of the carrier state in the Duchenne type muscular dystrophy. Ann Hum Genet. 1961 May;25:41–49. doi: 10.1111/j.1469-1809.1961.tb01495.x. [DOI] [PubMed] [Google Scholar]
  8. POJEROVA A., TOVAREK J. On enzymatic activity in the neonatal period. Acta Paediatr. 1959 May;48(3):213–222. [PubMed] [Google Scholar]
  9. SCHAPIRA G., DREYFUS J. C., SCHAPIRA F., KRUH J. Glycogenolytic enzymes in human progressive muscular dystrophy. Am J Phys Med. 1955 Feb;34(1):313–319. [PubMed] [Google Scholar]
  10. SIBLEY J. A., FLEISHER G. A. The clinical significance of serum aldolase. Proc Staff Meet Mayo Clin. 1954 Nov 10;29(23):591–603. [PubMed] [Google Scholar]
  11. SOLTAN H. C., BLANCHAER M. C. Activity of serum aldolase and lactic dehydrogenase in patients affected with Duchenne muscular dystrophy and in their immediate relatives. J Pediatr. 1959 Jan;54(1):27–33. doi: 10.1016/s0022-3476(59)80033-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES